Track topics on Twitter Track topics that are important to you
Prof Blay speaks with ecancer at WIN 2017 about open questions and the future of research in immunotherapy. Among the avenues to explore, Prof Blay outlines the variation in patients response rates and duration, with hyper-progressors posing as much a...
Original Article: Current and future immune approaches in precision medicineNEXT ARTICLE
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...